Antibodies

Items 1-10 of 168

Page
per page
Set Descending Direction
  1. anti-APRIL (human), mAb (blocking) (Mahya-1) (preservative free)
    AG-20B-0078PF
    AG-20B-0078PF-C100100 µg
    CHF 490.00
    AG-20B-0078PF-C500500 µg
    CHF 1'200.00
    anti-APRIL (human), mAb (blocking) (Mahya-1) (preservative free)
  2. anti-APRIL (mouse), mAb (blocking) (Centotto-1) (preservative free)
    AG-20B-0083PF
    AG-20B-0083PF-C100100 µg
    CHF 470.00
    AG-20B-0083PF-C500500 µg
    CHF 1'100.00
    anti-APRIL (mouse), mAb (blocking) (Centotto-1) (preservative free)
  3. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1)
    AG-27B-0001
    AG-27B-0001-C100100 µg
    CHF 455.00
    Schematic antibody structure.
  4. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (Biotin)
    AG-27B-0001B
    AG-27B-0001B-C100100 µg
    CHF 490.00
    Binding of APRIL (mouse) to BCMA is inhibited by anti-APRIL (mouse), mAb (rec.) (blocking) (APRY-1-1) (Prod. No. AG-27B-0001).
BCMA:Fc was coated on an ELISA plate at 1μg /ml. anti-APRIL (mouse) mAb (rec.) (blocking) (APRY-1-1) or an unrelated mA
  5. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (Fc LAEA-PG) (preservative free)
    AG-27B-0023PF
    AG-27B-0023PF-C100100 µg
    CHF 455.00
    AG-27B-0023PF-C500500 µg
    CHF 1'140.00
  6. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (preservative free)
    AG-27B-0001PF
    AG-27B-0001PF-C100100 µg
    CHF 455.00
    AG-27B-0001PF-C500500 µg
    CHF 1'140.00
    Binding of APRIL (mouse) to BCMA is inhibited by anti-APRIL (mouse), mAb (rec.) (blocking) (APRY-1-1) (Prod. No. AG-27B-0001).
BCMA:Fc was coated on an ELISA plate at 1μg /ml. anti-APRIL (mouse) mAb (rec.) (blocking) (APRY-1-1) or an unrelated mA
  7. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-3)
    AG-27B-0017
    AG-27B-0017-C100100 µg
    CHF 455.00
  8. anti-APRIL, mAb (Heaty-1)
    AG-20B-0082
    AG-20B-0082-C100100 µg
    CHF 490.00
  9. anti-BAFF (human), mAb (1-35-1)
    AG-20B-0037
    AG-20B-0037-C100100 µg
    CHF 400.00
    Detection of endogenous human BAFF using anti-BAFF (h) mAb (1-35-1)(AG-20B-0037).
Method: Neutrophils (CD15+) were stained with BAFF (h), mAb (1-35-1) (thick line) or an isotype control (thin line) at 10μg /ml each, revealed  with a second

Items 1-10 of 168

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.